Obamacare Lawsuits: Is the Affordable Care Act in Jeopardy?

Updated
Obamacare Lawsuits: Is the Affordable Care Act in Jeopardy?

The Patient Protection and Affordable Care Act, better known as Obamacare, has been controversial from the moment it was enacted. Many opponents have fought against it and now some have taken their grievances to court. Will numerous lawsuits prevent the Affordable Care Act from achieving its intended ends?

In the following video, Dan Caplinger, The Motley Fool's director of investment planning, reviews the various lawsuits that people have filed challenging aspects of the Affordable Care Act. Dan notes that the wide variety of different theories presents a formidable attack against Obamacare and he runs through the various suits pending. He concludes with a look at the investing ramifications, pointing out that for insurer UnitedHealth Group and hospital companies HCA Holdings and Community Health , the uncertainty involved could reverse their impressive share-price gains recently.

Understand what the fight against Obamacare is all about
Why are so many people angry about Obamacare? Find out more about all of the provisions that have raised so much controversy in only minutes. You can learn the critical facts you need to know in a special free report called "Everything You Need to Know About Obamacare." But don't hesitate; because it's not often that we release a FREE guide containing this much information and money-making advice. Please click here to access your free copy.


The article Obamacare Lawsuits: Is the Affordable Care Act in Jeopardy? originally appeared on Fool.com.

Fool contributor Dan Caplinger has no position in any stocks mentioned. The Motley Fool recommends UnitedHealth Group. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Advertisement